Featured Research

from universities, journals, and other organizations

New evidence of harmfulness of second-hand smoke: Cancer causing agent present in gaseous phase of cigarette smoke

Date:
March 21, 2012
Source:
Nemours
Summary:
Scientists have shown that a key protein involved in cell function and regulation is stopped by a substance present in cigarette smoke. The authors found a cancer-causing agent called reactive oxygen species present in the gaseous phase of cigarette smoke that has the ability to inhibit normal cell function. Exposure to secondhand smoke impaired the function of the sodium pump, necessary for healthy cell regulation.

A team of researchers led by A. K. Rajasekaran, PhD, Director of the Nemours Center for Childhood Cancer Research, has shown that a key protein involved in cell function and regulation is stopped by a substance present in cigarette smoke. Their work is published online in the American Journal of Physiology -- Lung Cell and Molecular Physiology.

Cigarette smoke is well recognized as a cause of lung cancer and is associated with many other forms of cancer in adults. Cigarette smoke has more than 4,000 components, many of which are linked to the development and progression of lung cancer. Evidence has shown secondhand smoke to be as dangerous as primary smoke due to its impact on the cells of the body.

In the study, the authors found a cancer-causing agent called reactive oxygen species (ROS) present in the gaseous phase of cigarette smoke that has the ability to inhibit normal cell function. Exposure to the secondhand smoke produced by as little as two cigarettes was found to almost completely stop the function of a cell's sodium pump within a few hours.

In normal cells, the sodium pump plays a critical role transporting potassium into the cell and sodium out of the cell. The competence of the cell's sodium pump, i.e., its inability to regulate sodium, is predictive of cell damage, disease progression and ultimately, survival.

"This is critical information with regard to secondhand smoke," said Dr. Rajasekaran. "We now know that one need not inhale the particulate matter present in secondhand smoke to suffer the consequence of smoking. Exposure to the gaseous substance alone, which you breathe while standing near a smoker, is sufficient to cause harm."

Dr. Lee Goodglick, Associate Professor in the Department of Pathology and Laboratory Medicine, UCLA, and co-senior author of the study, noted, "Few reliable lung cancer biomarkers that could predict survival, treatment options or response to therapy exist today. Even fewer have been recognized where the function of the biomarker is known, yielding important information about the mechanism of action. This study really accomplishes both."

This research is the latest finding in the compendium of evidence that supports protecting children from exposure to cigarette smoke. Excessive exposure to cigarette smoke during childhood can facilitate lung cancer development as children grow into adults.

While more research is needed to understand the consequences of sodium pump inhibition by cigarette smoke, this study reveals that secondhand smoke may be even more dangerous than previously thought.


Story Source:

The above story is based on materials provided by Nemours. Note: Materials may be edited for content and length.


Journal Reference:

  1. T. P. Huynh, V. Mah, V. B. Sampson, D. Chia, M. C. Fishbein, S. Horvath, M. Alavi, D. C. Wu, J. Harper, T. Sarafian, S. M. Dubinett, S. A. Langhans, L. Goodglick, A. K. Rajasekaran. Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. AJP: Lung Cellular and Molecular Physiology, 2012; DOI: 10.1152/ajplung.00384.2010

Cite This Page:

Nemours. "New evidence of harmfulness of second-hand smoke: Cancer causing agent present in gaseous phase of cigarette smoke." ScienceDaily. ScienceDaily, 21 March 2012. <www.sciencedaily.com/releases/2012/03/120321132101.htm>.
Nemours. (2012, March 21). New evidence of harmfulness of second-hand smoke: Cancer causing agent present in gaseous phase of cigarette smoke. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/03/120321132101.htm
Nemours. "New evidence of harmfulness of second-hand smoke: Cancer causing agent present in gaseous phase of cigarette smoke." ScienceDaily. www.sciencedaily.com/releases/2012/03/120321132101.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins